KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Research & Development: 2009-2024

Historic Research & Development for Bausch Health Companies (BHC) over the last 16 years, with Dec 2024 value amounting to $616.0 million.

  • Bausch Health Companies' Research & Development rose 13.70% to $166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $631.0 million, marking a year-over-year increase of 4.30%. This contributed to the annual value of $616.0 million for FY2024, which is 1.99% up from last year.
  • Bausch Health Companies' Research & Development amounted to $616.0 million in FY2024, which was up 1.99% from $604.0 million recorded in FY2023.
  • Bausch Health Companies' Research & Development's 5-year high stood at $616.0 million during FY2024, with a 5-year trough of $452.0 million in FY2020.
  • For the 3-year period, Bausch Health Companies' Research & Development averaged around $583.0 million, with its median value being $604.0 million (2023).
  • As far as peak fluctuations go, Bausch Health Companies' Research & Development fell by 4.03% in 2020, and later increased by 14.18% in 2023.
  • Over the past 5 years, Bausch Health Companies' Research & Development (Yearly) stood at $452.0 million in 2020, then increased by 2.88% to $465.0 million in 2021, then increased by 13.76% to $529.0 million in 2022, then rose by 14.18% to $604.0 million in 2023, then grew by 1.99% to $616.0 million in 2024.